ICD-10-CM Specific Coding Guidelines - Neoplasms Part II
TLDRThe transcript discusses the classification and coding of neoplasms, emphasizing the importance of understanding the nature and evolution of cancer for medical coders. It outlines the six classifications of neoplasms, including primary and secondary cancers, insitu malignancies, benign growths, uncertain neoplasms, and unspecified cases. The video provides detailed examples of coding scenarios, such as prostate cancer and bronchus cancer with metastasis to the hip bone, and explains the application of ICD-10-CM guidelines for sequencing codes, especially in cases where the treatment is directed at malignancy or secondary sites. The transcript also touches on the coding of anemia associated with cancer treatment and dehydration due to malignancy.
Takeaways
- 📚 Understanding the six classifications of neoplasms is crucial for accurate medical coding, including primary and secondary cancers, in situ, benign, uncertain, and unspecified neoplasms.
- 🧬 Primary cancer (malignancy) originates in a specific site, whereas secondary cancer (also known as metastasis) results from the spread of primary cancer to other sites.
- 🔍 In medical coding, the classification of neoplasms is found in the ICD-10-CM Neoplasms table, which is organized alphabetically and requires verification against the tabular list.
- 🌟 The nature of cancer evolves from normal cells to benign growths, and potentially to malignant tumors with the ability to metastasize, affecting the severity and treatment approach.
- 🗂️ When coding for neoplasms, it's important to first look up the code in the neoplasms table and then verify it in the tabular list to ensure accuracy.
- 💡 The sequencing of codes for primary and secondary cancers depends on the focus of treatment; if the treatment is for secondary cancer, it should be sequenced before the primary cancer.
- 🩺 For encounters where the reason is unclear, default to sequencing the primary cancer first, as per guideline C2a.
- 🩰 Anemia associated with malignancy is coded differently depending on whether it's related to chemotherapy, immunotherapy, or radiation therapy, with specific guidelines (C2 C1, C2 C2, C2 C3) for each scenario.
- 🚑 When a patient has both primary and secondary cancer and the documentation does not specify the reason for the encounter, the primary cancer is sequenced first as the default.
- 📈 The management of conditions like dehydration due to malignancy or complications from surgical procedures has specific sequencing guidelines (C2 C3, C2 C4) to ensure proper coding.
- 📋 Accurate coding for neoplasms requires a thorough understanding of the guidelines, attention to detail in the documentation, and the ability to apply the correct classification and sequencing based on the treatment provided.
Q & A
What are the six classifications of neoplasms mentioned in the transcript?
-The six classifications of neoplasms are primary cancer/malignancy, secondary cancer/malignancy (metastasis), in situ, benign, uncertain neoplasms, and unspecified.
What is the difference between primary and secondary cancer?
-Primary cancer is the original cancer that starts in a specific organ or part of the body. Secondary cancer, also known as metastasis, results from the spread of the primary cancer to other parts of the body.
What does 'in situ' mean in the context of cancer?
-In situ is a form of malignancy that is confined to the site of origin without invading the neighboring tissue. It can be malignant or may not be malignant.
How does the speaker describe the evolution of cancer from normal cells?
-The speaker describes the evolution of cancer as a process where normal cells begin to grow and multiply abnormally, forming benign cells. These benign cells can continue to grow and damage other cells within the gland, eventually becoming malignant or cancerous. The cancer cells can further become aggressive, leading to significant structural damage and the formation of tumors. These aggressive cancer cells can then spread to other parts of the body, forming secondary cancer.
What is the ICD-10 code for malignant neoplasm of the prostate?
-The ICD-10 code for malignant neoplasm of the prostate is C61.
How does the speaker instruct coders to handle cases where the treatment is for secondary cancer?
-The speaker instructs coders to sequence the secondary cancer (metastasis) first, followed by the primary cancer, according to guideline C2b. The treatment for secondary cancer should be considered first in the coding process.
What is the significance of the neoplasms table in ICD-10 coding?
-The neoplasms table in ICD-10 is significant because it provides the structure for coders to look up and verify the codes for different types of cancers. It lists the codes for primary and secondary cancers, in situ cancers, benign neoplasms, uncertain and unspecified behavior neoplasms, and more.
What is the ICD-10 code for malignant neoplasm of the unspecified part of the left bronchus or lung?
-The ICD-10 code for malignant neoplasm of the unspecified part of the left bronchus or lung is C34.92.
How does the speaker describe the process of coding for anemia associated with cancer treatment?
-The speaker describes the process of coding for anemia associated with cancer treatment by referring to guideline C2C1. If the anemia is caused by chemotherapy, the coder should sequence the anemia code (D64.8) first, followed by the malignancy code, and then the adverse effect code T451.X5A.
What is the correct sequence for coding a patient with primary breast cancer and anemia due to chemotherapy?
-The correct sequence for coding a patient with primary breast cancer and anemia due to chemotherapy is to first code the malignant neoplasm of the breast (C50.9), then the anemia code (D64.8), and finally the adverse effect code (T451.X5A).
How does the speaker address the issue of dehydration due to malignancy in the context of ICD-10 coding?
-The speaker addresses the issue of dehydration due to malignancy by referring to guideline C2C3. If the encounter is solely for the treatment of dehydration caused by the malignancy, the dehydration code should be sequenced first, followed by the malignancy code.
Outlines
📚 Introduction to Cancer Classifications
This paragraph introduces the six classifications of neoplasms relevant for medical coding. It explains primary and secondary cancers (including metastasis), in situ malignancies, benign growths, uncertain neoplasms, and unspecified cases. The discussion aims to clarify the nature and evolution of cancer, using the prostate as an example to illustrate how cancer progresses from normal cells to high-grade malignancy and potential metastasis.
🧬 Understanding the Neoplasms Table in ICD-10-CM
This section delves into the specifics of the neoplasms table in the ICD-10-CM manual, detailing its structure and how to use it for coding malignancies. It emphasizes that not all cancers are coded from this table, with exceptions like sarcoma and lipoma. The paragraph also discusses the importance of verifying codes using the tabular list and understanding the difference between cancerous and non-cancerous classifications.
🩺 Coding Scenario: Prostate Cancer Treatment
A coding scenario is presented where a patient seeks treatment for prostate cancer. The paragraph explains that without specific mention of secondary cancer, the default code for primary cancer is used. It guides through looking up the ICD-10-CM code for prostate cancer (C61) and emphasizes the importance of verifying the code in the tabular list to identify any additional necessary codes, such as those for hormone sensitivity status and Rising PSA following treatment.
🌟 Coding Guidelines for Primary and Secondary Cancers
This paragraph focuses on the coding guidelines for primary and secondary cancers. It explains the sequence in which to code for these conditions, particularly when the treatment is for the secondary cancer. The guidelines advise sequencing the secondary cancer (metastasis) first, followed by the primary cancer, with exceptions for specific treatments like chemotherapy and immunotherapy.
📈 Applying Coding Guidelines to Anemia and Dehydration
The paragraph discusses the application of coding guidelines for conditions like anemia and dehydration in the context of malignancies. It outlines how to sequence codes when the anemia is caused by chemotherapy or radiotherapy and when the encounter is solely for managing dehydration due to the malignancy. The guidelines also address coding for complications from surgical procedures and treatment for secondary cancers with a history of previously excised primary malignancies.
🛠️ Coding Challenge: Anemia Due to Chemotherapy
A coding challenge is presented where a patient with male primary breast cancer is diagnosed with anemia due to chemotherapy. The physician prescribes iron tablets and administers a transfusion. The paragraph guides through the process of identifying the correct ICD-10-CM codes for the encounter, emphasizing the use of guideline C2 C2 for sequencing the anemia code first, followed by the malignancy code, and then the adverse effect code for the chemotherapy.
🎯 Final Coding Scenario and Summary
The final paragraph wraps up the discussion with a coding scenario involving a patient diagnosed with anemia due to breast cancer chemotherapy. It highlights the correct application of the ICD-10-CM codes, emphasizing the importance of following the sequencing guidelines for anemia related to chemotherapy. The paragraph concludes with a reminder to always verify the codes using the tabular list and to be mindful of the differences in coding for various types of treatments and conditions.
Mindmap
Keywords
💡Neoplasms
💡Primary Cancer
💡Secondary Cancer
💡In Situ
💡Benign
💡Uncertain Neoplasms
💡Unspecified Neoplasms
💡ICD-10-CM
💡Medical Coding
💡Cancer Evolution
Highlights
Discussion on the six classifications of neoplasms in medical coding.
Explanation of primary and secondary cancer, including the concept of metastasis.
Description of in situ malignancy as a form of cancer confined to the site of origin.
Differentiation between benign cells and uncertain neoplasms in medical coding.
Clarification on unspecified neoplasms due to insufficient information in medical records.
Illustration of how cancer evolves from normal cells to high-grade malignancy.
Use of the neoplasms table in ICD-10-CM for coding malignancies.
Explanation of the arrangement of neoplasms codes in the ICD-10-CM table.
Coding practice for primary cancer of the prostate gland as an example.
Guidelines for coding when a patient has both primary and secondary cancer.
Importance of sequencing secondary cancer first when it is being treated.
Application of guidelines for coding anemia associated with malignancy.
Special considerations for coding dehydration due to malignancy.
Coding for complications resulting from surgical procedures related to malignancy.
Challenge exercise involving coding for a patient with primary breast cancer and secondary cancer to the hip bone.
Practical application of coding guidelines for anemia caused by chemotherapy.
Emphasis on the importance of following coding guidelines for accurate medical coding.
Discussion on the management of anemia in the context of cancer treatment, including the use of adverse effect codes.
Transcripts
Browse More Related Video
ICD-10-CM Specific Coding Guidelines - Neoplasms
ICD 10 CM Chapter Specific Guidelines I. C2
Complete Guide to the Neoplasm Table in ICD-10-CM for Beginner Medical Coders
ICD-10-CM Specific Coding Guidelines - Neoplasms
ICD-10-CM BASICS Episode 1 (ICD-10-CM Book Layout)
2023 ICD 10 CM coding guidelines for chapter 9 diseases of circulatory system part 6
5.0 / 5 (0 votes)
Thanks for rating: